Edesa Biotech Inc.

NASDAQ: EDSA · Real-Time Price · USD
2.24
-0.02 (-0.88%)
At close: Aug 15, 2025, 2:57 PM

Edesa Biotech Balance Sheet Statement

Financials in USD. Fiscal year is October - September.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Sep 30, 2024 Sep 30, 2023 Sep 30, 2022 Sep 30, 2021
Cash & Equivalents
1.04M 5.36M 7.09M 7.84M
Short-Term Investments
n/a n/a n/a n/a
Long-Term Investments
n/a n/a n/a n/a
Other Long-Term Assets
41.15K 173.49K 171.46K -0.00
Receivables
270.91K 626.54K 1.26M 3.3M
Inventory
n/a n/a -1.26M n/a
Other Current Assets
367.39K 448.91K n/a 948.64K
Total Current Assets
1.68M 6.44M 9.09M 12.09M
Property-Plant & Equipment
18.36K 100.08K 31.16K 111.56K
Goodwill & Intangibles
2.08M 2.18M 2.28M 2.38M
Total Long-Term Assets
2.14M 2.45M 2.48M 2.49M
Total Assets
3.81M 8.89M 11.58M 14.58M
Account Payables
n/a 1.75M 2.12M 1.38M
Deferred Revenue
n/a n/a -2.12M -1.38M
Short-Term Debt
n/a n/a 18.98K n/a
Other Current Liabilities
1.81M n/a -18.98K n/a
Total Current Liabilities
1.83M 1.82M 2.14M 1.46M
Long-Term Debt
n/a n/a n/a n/a
Other Long-Term Liabilities
n/a n/a 43.66K 47.2K
Total Long-Term Liabilities
n/a 19.77K 43.66K 67.71K
Total Liabilities
1.83M 1.84M 2.18M 1.53M
Total Debt
19.87K 94.49K 18.98K 99.32K
Common Stock
47.24M 46.64M 42.47M 34.89M
Retained Earnings
-58.59M -52.42M -44.04M -26.5M
Comprehensive Income
-242.61K -214.65K -213.6K -205.26K
Shareholders Equity
1.98M 7.05M 9.39M 13.06M
Total Investments
n/a -233K n/a n/a